Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 495.94M | $ 0 | $ 95.5M | 5.19 |
3/31/2025 | $ 551.39M | $ 0 | $ 112.59M | 4.9 |
12/31/2024 | $ 639.86M | $ 0 | $ 110.85M | 5.77 |
9/30/2024 | $ 710.9M | $ 0 | $ 105.68M | 6.73 |
6/30/2024 | $ 757.21M | $ 0 | $ 105.09M | 7.21 |
3/31/2024 | $ 884.04M | $ 0 | $ 97.91M | 9.03 |
12/31/2023 | $ 998.33M | $ 0 | $ 115.21M | 8.67 |
9/30/2023 | $ 893.49M | $ 0 | $ 91.95M | 9.72 |
6/30/2023 | $ 939.62M | $ 0 | $ 99.85M | 9.41 |
3/31/2023 | $ 963.67M | $ 0 | $ 103.38M | 9.32 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for INTELLIA THERAPEUTICS INC is calculated as follows: (AssetsC [ $ 416.25M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 55.87M ]
(=) Quick Ratio [ 7.45 ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |